Mixed allergen compositions and methods for using the same

US10064936B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10064936-B2
Application numberUS-201615048609-A
CountryUS
Kind codeB2
Filing dateFeb 19, 2016
Priority dateFeb 20, 2015
Publication dateSep 4, 2018
Grant dateSep 4, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Mixed allergen compositions of two or more different allergens are provided. In some instances, the mixed allergen compositions include: a nut allergen; an animal allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin. Also provided are methods of administering the mixed allergen compositions to a subject. The mixed allergen compositions find use in a variety of applications, including health maintenance, immune balance, gut balance, immune support, health improvement and therapeutic applications.

First claim

Opening claim text (preview).

That which is claimed is: 1. A mixed allergen composition comprising: a nut allergen selected from the group consisting of a peanut allergen, an almond allergen, a walnut allergen, a cashew allergen, a hazelnut allergen, a pecan allergen and a pistachio allergen; an animal allergen selected from the group consisting of a shrimp allergen, a cod allergen, and a salmon allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin, wherein the composition comprises equal parts by weight of the nut allergen, the animal allergen, and the non-nut plant allergen, if present. 2. The mixed allergen composition of claim 1 , wherein the composition comprises the non-nut plant allergen. 3. The mixed allergen composition of claim 1 , wherein the composition comprises the biotic agent. 4. The mixed allergen composition of claim 3 , wherein the biotic agent comprises a probiotic. 5. The mixed allergen composition of claim 3 , wherein the biotic agent comprises a prebiotic. 6. The mixed allergen composition of claim 1 , wherein the composition comprises the vitamin. 7. The mixed allergen composition of claim 1 , wherein the composition comprises the non-nut plant allergen, and the vitamin. 8. The mixed allergen composition of claim 1 , wherein the amount of each allergen present in the composition ranges from 15 to 99.9 wt. %. 9. The mixed allergen composition of claim 1 , wherein the composition further comprises a physiologically acceptable delivery vehicle. 10. The mixed allergen composition of claim 9 , wherein the physiologically acceptable delivery vehicle is an ingestible delivery vehicle. 11. The mixed allergen composition of claim 9 , wherein the physiologically acceptable delivery vehicle is a topical delivery vehicle. 12. The mixed allergen composition of claim 9 , wherein the physiologically acceptable delivery vehicle is an injectable delivery vehicle. 13. A method of treating an allergy in a human subject in need thereof, the method comprising administering the mixed allergen composition of claim 1 to the subject. 14. The method of claim 13 , wherein the subject is a juvenile. 15. The method of claim 13 , wherein the subject is an adult. 16. The method of claim 15 , wherein the subject is pregnant with a fetus or suckling an infant. 17. The mixed allergen composition of claim 1 , wherein the non-nut plant allergen is selected from the group consisting of a wheat allergen, a sesame allergen, and an oat allergen. 18. The mixed allergen composition of claim 1 , wherein the composition further comprises an animal allergen selected from the group consisting of a chicken egg allergen, a cow milk allergen, and a crab allergen. 19. The mixed allergen composition of claim 1 , wherein the mixed allergen composition further comprises a soy allergen. 20. The mixed allergen composition of claim 1 , wherein the vitamin is selected from the group consisting of vitamin D and vitamin C. 21. The mixed allergen composition of claim 20 , wherein the vitamin is vitamin D. 22. The method of claim 13 , wherein the allergy is a food allergy. 23. The method of claim 22 , wherein the allergy is a single food allergy. 24. The method of claim 22 , wherein the allergy is a multiple food allergy.

Assignees

Inventors

Classifications

  • Immunomodulators · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Drugs for disorders of the alimentary tract or the digestive system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10064936B2 cover?
Mixed allergen compositions of two or more different allergens are provided. In some instances, the mixed allergen compositions include: a nut allergen; an animal allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin. Also provided are methods of administering the mixed allergen compositions to a subject. The mixed allergen compositions find use in a variety of …
Who is the assignee on this patent?
Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification A61K39/35. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).